MMR Deficiency

What MMR Deficiency Means

MMR deficiency, also called deficient DNA mismatch repair or dMMR, refers to cells that have lost the ability to fix mistakes made when DNA is copied during cell division. Normally, a group of genes called mismatch repair genes work to correct these errors and keep DNA stable. When these genes don’t work properly, errors build up, causing many mutations in the DNA. This can increase the chance that cells become cancerous.

Why MMR Deficiency Matters in Cancer Care

Knowing whether a tumor has MMR deficiency is important because it can affect how the cancer behaves and responds to treatment. Tumors with dMMR often have many mutations, which may make them more visible to the immune system or more sensitive to certain drugs. Testing for MMR deficiency is especially common in colorectal, gastrointestinal, and endometrial cancers but can also be relevant in other cancers and inherited conditions like Lynch syndrome. This information can help doctors decide on treatment options and predict how well a tumor might respond.

Where You Might See the Term and What It Means

You may encounter the term MMR deficiency, dMMR, deficient mismatch repair, or mismatch repair deficiency in medical reports, pathology results, treatment plans, or discussions about clinical trials and drug options. Because these terms are used interchangeably, it’s helpful to compare the wording and ask your care team to explain what it means for your specific case. Finding MMR deficiency in a tumor is not a diagnosis by itself, nor does it directly tell you what treatment you will receive. It is one piece of information that doctors use alongside other tests and clinical details.

How Doctors Use MMR Deficiency Information

Doctors may test for MMR deficiency to help guide treatment decisions, such as whether certain immunotherapy drugs might be effective. Testing can also help identify inherited conditions like Lynch syndrome, which may affect cancer risk for family members. This information can be part of diagnosis, staging, treatment planning, and follow-up care.

Common Questions and Confusions

Because MMR deficiency has several names and appears in different contexts, it can be confusing. Patients often wonder what it means for their cancer type, treatment options, and prognosis. Good questions to ask your care team include: What does MMR deficiency mean for my cancer? How does it affect my treatment choices? Is this related to inherited cancer risk? What tests were done to find this? Understanding the context helps avoid misunderstandings.

Reading MMR Deficiency in Context

Always consider MMR deficiency as part of a larger medical picture. It is not a standalone diagnosis or treatment plan. If you see it in a report or discussion, ask how it fits with other findings and what it means for your care. Your healthcare team can explain how this information is used to personalize your treatment.

Safety and Next Steps

This explanation is for education only and does not replace medical advice. If you see the term MMR deficiency or dMMR in your medical record or report, the safest next step is to ask your care team what it means in your exact report, test result, treatment plan, or symptom discussion. They can help you understand how this information applies to your care and what options may be best for you.